Notice Number: NOT-OD-16-048
Release Date: December 30, 2015
National Institutes of Health (NIH)
The FY 2016 Consolidated Appropriations Act, 2016 (Public Law 114-113) signed into law on December 18, 2015, provides funding to NIH for the fiscal year ending September 30, 2016. NIH Notice NOT-OD-16-044 provides information on statutory provisions that limit the use of funds on NIH grant, cooperative agreement, and contract awards for FY2016. The intent of this Notice is to amend NOT-OD-16-044 to include the modified FY2016 language regarding the Restriction on the Purchase of Sterile Needles as follows:
(10) Restriction on Purchase of Sterile Needles (Section 520)
"Notwithstanding any other provision of this Act, no funds appropriated in this Act shall be used to purchase sterile needles or syringes for the hypodermic injection of any illegal drug: Provided, That such limitation does not apply to the use of funds for elements of a program other than making such purchases if the relevant State or local health department, in consultation with the Centers for Disease Control and Prevention, determines that the State or local jurisdiction, as applicable, is experiencing, or is at risk for, a significant increase in hepatitis infections or an HIV outbreak due to injection drug use, and such program is operating in accordance with State and local law."
Division of Grants Policy
Office of Policy for Extramural Research Administration (OPERA)
Office of Extramural Research
National Institutes of Health
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files.